ME

MedPacto, Inc.

Develops biomarker-based precision therapies for oncology and other incurable diseases.

235980 | KO

Overview

Corporate Details

ISIN(s):
KR7235980000
LEI:
Country:
South Korea
Address:
서울특별시 서초구 명달로 92, 보림빌딩, 서초구
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

MedPacto, Inc. is a clinical-stage biotechnology company specializing in the discovery and development of innovative, biomarker-based therapeutics. Utilizing a genome-based drug discovery platform, the company aims to deliver precision medicine and personalized therapies. Its research and development pipeline focuses on creating first-in-class treatments for incurable diseases, with core areas in oncology, autoimmune disorders, metabolic diseases, and bone and joint diseases. A key scientific strategy includes modulating the tumor microenvironment to enhance the efficacy of anticancer drugs. The company is committed to transforming novel targets into therapeutic solutions for patients with unmet medical needs.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-14 00:00
Interim Report
반기보고서 (2025.06)
Korean 1.3 MB
2025-07-31 00:00
Share Issue/Capital Change
주식매수선택권부여에관한신고
Korean 17.3 KB
2025-07-17 00:00
Report Publication Announcement
기업설명회(IR)개최
Korean 6.8 KB
2025-06-11 00:00
Legal Proceedings Report
투자판단관련주요경영사항(임상시험결과) (진행성 NSCLC를 대상으로 한 백토서팁과 더발루맙 병용요법의 제 1b/2a상,…
Korean 15.1 KB
2025-05-15 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 1.3 MB
2025-03-28 00:00
Post-Annual General Meeting Information
정기주주총회결과
Korean 28.6 KB
2025-03-28 00:00
Share Issue/Capital Change
주식매수선택권부여에관한신고
Korean 14.9 KB
2025-03-21 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 123.2 KB
2025-03-21 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 88.7 KB
2025-03-20 00:00
Audit Report / Information
감사보고서제출
Korean 25.5 KB
2025-03-20 00:00
Annual / Quarterly Financial Statement
사업보고서 (2024.12)
Korean 353.8 KB
2025-03-13 00:00
Pre-Annual General Meeting Information
주주총회소집결의
Korean 16.3 KB
2025-03-13 00:00
Pre-Annual General Meeting Information
주주총회소집공고
Korean 187.9 KB
2025-03-13 00:00
Pre-Annual General Meeting Information
주주총회집중일개최사유신고
Korean 4.8 KB
2025-03-13 00:00
Proxy Solicitation & Information Statement
의결권대리행사권유참고서류
Korean 177.3 KB

Automate Your Workflow. Get a real-time feed of all MedPacto, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for MedPacto, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for MedPacto, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

HireQuest, Inc. Logo
A franchisor of staffing solutions offering temporary labor and skilled placement to diverse industries.
United States of America
HQI
H.I.S. Co., Ltd. Logo
A major Japanese travel agency providing global tour packages, lodging, and transport.
Japan
9603
Hit Co., Ltd. Logo
Specialized OOH advertising firm providing digital & static billboards in high-visibility areas.
Japan
378A
HLB Therapeutics Co.,Ltd. Logo
Develops innovative drugs for rare eye diseases and brain tumors, with vaccine logistics.
South Korea
115450
HONYAKU Center Inc. Logo
Provides industrial translation and interpreting for patent, legal, and corporate clients.
Japan
2483
A holding company for advanced materials, AI/data solutions, mobility, and global logistics.
South Korea
487570
Human Metabolome Technologies, Inc. Logo
A leader in metabolomics, providing CE-MS analysis to support R&D in biotech, pharma, and food.
Japan
6090
Hybrigenics SA Logo
R&D provider of molecular interaction analysis to accelerate drug discovery for life science sectors.
France
ALHYG
Korean CRO offering end-to-end clinical trial services for pharma & bio ventures.
South Korea
187660
HYUNDAI BIOSCIENCE CO., LTD. Logo
Clinical-stage biotech developing safer antiviral & anticancer drugs via advanced drug delivery systems.
South Korea
048410

Talk to a Data Expert

Have a question? We'll get back to you promptly.